1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dopamine Agonists
1.2.3 Levodopa
1.2.4 Glutamate Antagonist
1.2.5 Apomorphine
1.2.6 COMT Inhibitors Anticholinergics
1.2.7 MAO-B Inhibitors
1.2.8 Other Drugs
1.3 Market by Application
1.3.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Healthcare Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Parkinson's Disease Treatments Market Perspective (2017-2028)
2.2 Parkinson's Disease Treatments Growth Trends by Region
2.2.1 Parkinson's Disease Treatments Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Parkinson's Disease Treatments Historic Market Size by Region (2017-2022)
2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Region (2023-2028)
2.3 Parkinson's Disease Treatments Market Dynamics
2.3.1 Parkinson's Disease Treatments Industry Trends
2.3.2 Parkinson's Disease Treatments Market Drivers
2.3.3 Parkinson's Disease Treatments Market Challenges
2.3.4 Parkinson's Disease Treatments Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Treatments Players by Revenue
3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2017-2022)
3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2017-2022)
3.2 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Treatments Revenue
3.4 Global Parkinson's Disease Treatments Market Concentration Ratio
3.4.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2021
3.5 Parkinson's Disease Treatments Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Treatments Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Parkinson's Disease Treatments Breakdown Data by Type
4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2017-2022)
4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2023-2028) 5 Parkinson's Disease Treatments Breakdown Data by Application
5.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2017-2022)
5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Parkinson's Disease Treatments Market Size (2017-2028)
6.2 North America Parkinson's Disease Treatments Market Size by Type
6.2.1 North America Parkinson's Disease Treatments Market Size by Type (2017-2022)
6.2.2 North America Parkinson's Disease Treatments Market Size by Type (2023-2028)
6.2.3 North America Parkinson's Disease Treatments Market Share by Type (2017-2028)
6.3 North America Parkinson's Disease Treatments Market Size by Application
6.3.1 North America Parkinson's Disease Treatments Market Size by Application (2017-2022)
6.3.2 North America Parkinson's Disease Treatments Market Size by Application (2023-2028)
6.3.3 North America Parkinson's Disease Treatments Market Share by Application (2017-2028)
6.4 North America Parkinson's Disease Treatments Market Size by Country
6.4.1 North America Parkinson's Disease Treatments Market Size by Country (2017-2022)
6.4.2 North America Parkinson's Disease Treatments Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Parkinson's Disease Treatments Market Size (2017-2028)
7.2 Europe Parkinson's Disease Treatments Market Size by Type
7.2.1 Europe Parkinson's Disease Treatments Market Size by Type (2017-2022)
7.2.2 Europe Parkinson's Disease Treatments Market Size by Type (2023-2028)
7.2.3 Europe Parkinson's Disease Treatments Market Share by Type (2017-2028)
7.3 Europe Parkinson's Disease Treatments Market Size by Application
7.3.1 Europe Parkinson's Disease Treatments Market Size by Application (2017-2022)
7.3.2 Europe Parkinson's Disease Treatments Market Size by Application (2023-2028)
7.3.3 Europe Parkinson's Disease Treatments Market Share by Application (2017-2028)
7.4 Europe Parkinson's Disease Treatments Market Size by Country
7.4.1 Europe Parkinson's Disease Treatments Market Size by Country (2017-2022)
7.4.2 Europe Parkinson's Disease Treatments Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Treatments Market Size (2017-2028)
8.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type
8.2.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Parkinson's Disease Treatments Market Share by Type (2017-2028)
8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Application
8.3.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Parkinson's Disease Treatments Market Share by Application (2017-2028)
8.4 Asia-Pacific Parkinson's Disease Treatments Market Size by Region
8.4.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Parkinson's Disease Treatments Market Size (2017-2028)
9.2 Latin America Parkinson's Disease Treatments Market Size by Type
9.2.1 Latin America Parkinson's Disease Treatments Market Size by Type (2017-2022)
9.2.2 Latin America Parkinson's Disease Treatments Market Size by Type (2023-2028)
9.2.3 Latin America Parkinson's Disease Treatments Market Share by Type (2017-2028)
9.3 Latin America Parkinson's Disease Treatments Market Size by Application
9.3.1 Latin America Parkinson's Disease Treatments Market Size by Application (2017-2022)
9.3.2 Latin America Parkinson's Disease Treatments Market Size by Application (2023-2028)
9.3.3 Latin America Parkinson's Disease Treatments Market Share by Application (2017-2028)
9.4 Latin America Parkinson's Disease Treatments Market Size by Country
9.4.1 Latin America Parkinson's Disease Treatments Market Size by Country (2017-2022)
9.4.2 Latin America Parkinson's Disease Treatments Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Treatments Market Size (2017-2028)
10.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type
10.2.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Parkinson's Disease Treatments Market Share by Type (2017-2028)
10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application
10.3.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Parkinson's Disease Treatments Market Share by Application (2017-2028)
10.4 Middle East & Africa Parkinson's Disease Treatments Market Size by Country
10.4.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Parkinson's Disease Treatments Introduction
11.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Parkinson's Disease Treatments Introduction
11.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Parkinson's Disease Treatments Introduction
11.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Parkinson's Disease Treatments Introduction
11.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.4.5 Teva Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Impax
11.6.1 Impax Company Details
11.6.2 Impax Business Overview
11.6.3 Impax Parkinson's Disease Treatments Introduction
11.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.6.5 Impax Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Treatments Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.7.5 Abbvie Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Company Details
11.8.2 Bausch Health Business Overview
11.8.3 Bausch Health Parkinson's Disease Treatments Introduction
11.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.8.5 Bausch Health Recent Developments
11.9 Lundbeck
11.9.1 Lundbeck Company Details
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Parkinson's Disease Treatments Introduction
11.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.9.5 Lundbeck Recent Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Details
11.10.2 Sun Pharma Business Overview
11.10.3 Sun Pharma Parkinson's Disease Treatments Introduction
11.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.10.5 Sun Pharma Recent Developments
11.11 Wockhardt
11.11.1 Wockhardt Company Details
11.11.2 Wockhardt Business Overview
11.11.3 Wockhardt Parkinson's Disease Treatments Introduction
11.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.11.5 Wockhardt Recent Developments
11.12 Acadia
11.12.1 Acadia Company Details
11.12.2 Acadia Business Overview
11.12.3 Acadia Parkinson's Disease Treatments Introduction
11.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.12.5 Acadia Recent Developments
11.13 UCB
11.13.1 UCB Company Details
11.13.2 UCB Business Overview
11.13.3 UCB Parkinson's Disease Treatments Introduction
11.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2017-2022)
11.13.5 UCB Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
